18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series

• Published in: BMC pulmonary medicine Vol. 13; no. 1; p. 14
• Main Authors: Heysell, Scott K, Thomas, Tania A, Sifri, Costi D, Rehm, Patrice K, Houpt, Eric R
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 21.03.2013; BioMed Central
• Subjects: Aged; Antitubercular Agents - therapeutic use; Care and treatment; Case Report; Drug Resistance, Bacterial; Female; Fluorodeoxyglucose F18; Health aspects; Humans; Male; Mycobacterium; PET imaging; Positron-Emission Tomography - methods; Pulmonology; Radiopharmaceuticals; Treatment Outcome; Tuberculosis; Tuberculosis - diagnostic imaging; Tuberculosis - drug therapy
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/1471-2466-13-14

F-fluorodeoxyglucose positron emission tomography (FDG-PET) is increasingly used to investigate for malignancy in the evaluation of pulmonary nodules, yet both active tuberculosis (TB) and malignancy have high uptake of FDG. Definitive diagnosis of TB can be further hindered in patients without growth of the organism from sputum. We describe a series of four representative cases of TB in varying disease state originally imaged by FDG-PET during evaluation for malignancy. Decisions regarding treatment for active TB in the presence of negative cultures and the evolving understanding of the spectrum of the TB disease state are discussed. FDG-PET may possess a role in the diagnosis of active TB infection in settings where conventional microbiological methods are unavaiable and holds particular promise for monitoring response to therapy in cases of unsettled treatment duration such as multidrug-resistant TB or in extrapulmonary TB.